Cambridge, ISPA Develop Tool to Identify Myeloid Leukemia Risk
newscatcher
2023-08-24 15:31
Cambridge, ISPA Develop Tool to Identify Myeloid Leukemia Risk
Scientists have created a new test for identifying people at risk of developing acute myeloid leukaemia and related cancers, years before they do. The new platform, 'MN-predict', will allow doctors and scientists to identify those at risk and to design new treatments to prevent them from developing these potentially lethal cancers. Researchers at the Wellcome-MRC Cambridge Stem Cell Institute (CSCI), the University of Cambridge's Department of Haematology, and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) analysed data from more than 400,000 individuals participating in the United Kingdom Biobank.

https://www.miragenews.com/cambridge-ispa-develop-tool-to-identify-myeloid-1071676/

#miragenews
Piilota kommentit Kommentit (0)

Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.